Noticias de NVO_US
Noticias del mercado
Últimas noticias sobre NVO_US — 895 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Oral Wegovy launches in Germany, but shares lag 28% below January high. Self-pay model and pipeline
Novo-Nordisk stock is in focus as the company launches its Wegovy weight-loss pill in Germany, addin
Las acciones de Novo Nordisk cotizan por debajo de su máximo de 52 semanas mientras los inversores evalúan el lanzamiento de septiembre de 2026
Obesity/GLP-1 drug market heats up as oral pills scale and new injectables emerge.
Novo Nordisk stock trades just below recent highs as the Wegovy tablet launch in Germany and a multi
Bagsværd, Denmark, 31 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026. Under the programme initi
Página 2 de 45